AtriCure, Inc. Forecast, price target & analysts
AtriCure, Inc. Target price 2025 - Analyst rating & recommendation
AtriCure, Inc. Classifications & Recommendation:
AtriCure, Inc. Price Target
| Target Price | $51.00 |
| Price | $41.04 |
| Potential |
24.27%
register free of charge
|
| Number of Estimates | 11 |
|
11 Analysts have issued a price target AtriCure, Inc. 2026 .
The average AtriCure, Inc. target price is $51.00.
This is
24.27%
register free of charge
$67.20
63.74%
register free of charge
$40.40
1.56%
register free of charge
|
|
| A rating was issued by 15 analysts: 14 Analysts recommend AtriCure, Inc. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the AtriCure, Inc. stock has an average upside potential 2026 of
24.27%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2030
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 465.31 | 543.96 |
| 16.55% | 16.90% | |
| EBITDA Margin | -7.95% | 10.44% |
| 33.75% | 231.33% | |
| Net Margin | -9.61% | -3.48% |
| 26.00% | 63.77% |
11 Analysts have issued a sales forecast AtriCure, Inc. 2025 . The average AtriCure, Inc. sales estimate is
This results in the following potential growth metrics:
10 Analysts have issued an AtriCure, Inc. EBITDA forecast 2025. The average AtriCure, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
11 AtriCure, Inc. Analysts have issued a net profit forecast 2025. The average AtriCure, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2030
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.95 | -0.38 |
| 43.94% | 60.00% | |
| P/E | negative | |
| EV/Sales | 3.60 |
11 Analysts have issued a AtriCure, Inc. forecast for earnings per share. The average AtriCure, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Current AtriCure, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Oct 30 2025 |
| Needham |
Locked
➜
Locked
|
Locked | Jul 30 2025 |
| JMP Securities |
Locked
➜
Locked
|
Locked | Apr 30 2025 |
| Needham |
Locked
➜
Locked
|
Locked | Apr 30 2025 |
| UBS |
Locked
➜
Locked
|
Locked | Apr 30 2025 |
| Citizens Capital Markets |
Locked
➜
Locked
|
Locked | Apr 02 2025 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Mar 28 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Oct 30 2025 |
|
Locked
Needham:
Locked
➜
Locked
|
Jul 30 2025 |
|
Locked
JMP Securities:
Locked
➜
Locked
|
Apr 30 2025 |
|
Locked
Needham:
Locked
➜
Locked
|
Apr 30 2025 |
|
Locked
UBS:
Locked
➜
Locked
|
Apr 30 2025 |
|
Locked
Citizens Capital Markets:
Locked
➜
Locked
|
Apr 02 2025 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Mar 28 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
